Hyperprolactinemia Induced by Antipsychotics: From Diagnosis to Treatment Approach

E-ISSN： 2212-3873|17|1|38-55

ISSN： 1871-5303

Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.17, Iss.1, 2017-06, pp. : 38-55

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Melperone treatment in an organic delusional syndrome induced by hyperprolactinemia: a case report

By Soygur H. Palaoglu O. Altinors N. Corapcioglu D. Erdogan G. Ayhan I.H.

European Neuropsychopharmacology, Vol. 7, Iss. 2, 1997-05 ,pp. : 161-163

Elsevier

Access to resources Recommend Favorite

Current treatment options for hyperprolactinemia

By Faje Alexander

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 12, 2013-08 ,pp. : 1611-1625

Informa Healthcare

Access to resources Recommend Favorite

The Diagnosis and Treatment of Raynaud's Phenomenon: A Practical Approach

By Pope Janet E.

Drugs, Vol. 67, Iss. 4, 2007-01 ,pp. : 517-525

Adis International

Access to resources Recommend Favorite

Drug-induced hypo- and hyperprolactinemia: mechanisms, clinical and therapeutic consequences

By Voicu Victor

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 8, 2013-08 ,pp. : 955-968

Informa Healthcare

Access to resources Recommend Favorite

Atypical antipsychotics in the treatment of bipolar disorder

By Strakowski Stephen M Del Bello Melissa P Adler Caleb M Keck Jr Paul E

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 5, 2003-05 ,pp. : 751-760

Informa Healthcare

Access to resources Recommend Favorite